A Study to Assess the PK, PD, Safety and Tolerability of Eplontersen in Healthy Chinese Volunteers

Clinical trial NCT06527755 · COMPLETED

Trial details

NCT number: NCT06527755
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Transthyretin-mediated Amyloidosis

Start date: 2024-08-06
Primary completion: 2024-09-11
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.